Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

Go to Regulatory Recap News

Subscribe for Weekly Updates

The Advocacy &  Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.

Subscribe

Advocacy Opportunity Psychedelics

FDA Seeks Input on Potential Therapeutic Use of Psychedelic Drugs

A public hearing will be held on September 14th. with written comments accepted until October 5th.

Read More →

July 20, 2026

Cost Containment

Connecticut Reduces Drug Reimbursement Rates

Updates to the Practitioner Fee Schedule switch from an AWP-plus reimbursement model to an AWP-discount model.

Read More →

July 20, 2026

Advocacy Opportunity Cost Containment Pharmacy Data

California P&T Committee Reviews Rising Drug Costs and Utilization Patterns

The Committee is focused on high-cost and high-utilization medications, including GLP-1s, PPIs, anticonvulsants, topical agents, and biologics.

Read More →

July 20, 2026

Advocacy Opportunity Cost Containment Treatment Guidelines

Florida’s Physician Dispensing Rules Continue to Be Evaluated

Commenters asked the DWC to clarify the scope of pharmacy and pharmacist definitions and prior authorization requirements.

Read More →

July 20, 2026

Access to Care Technology

SAWCA Convention Recap

Access to care and AI emerged as dominant themes of the conference.

Read More →

July 20, 2026

Presumptions

Alaska Revises Cancer Presumption for Firefighters

While cancer coverage remains the same, timelines and qualifications for coverage have been adjusted.

Read More →

July 20, 2026

Advocacy Opportunity Treatment Guidelines

Texas Proposes Updates to Impairment Rating Guidelines

The Fourth Edition of the AMA Guidelines have been in use since 2000 and would be updated to the Six Edition, published 2025.

Read More →

July 20, 2026

Ancillary Services

CMS Proposes Updates to Expand Access to Home Healthcare

The proposed rule includes an estimated 2.4% increase in Medicare payments to home health agencies to support access to care.

Read More →

July 13, 2026

Billing & Payments Claims Procedures

Florida Extends Deadlines for Medical Reimbursement Disputes

Providers now have 60 days to petition the DWC when carriers adjust or disallow payment, while carriers have 45 days to respond to petitions.

Read More →

July 13, 2026

« Previous 1 … 6 7 8 9 10 … 64 Next »

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.

hello world!

Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

INFOGRAPHIC: Current State of Complex Claims in Workers’ Comp

Statistics from recent studies across the industry shed light on complex claims in workers' compensation.

State of the Nation

Sandy Shtab, VP of Industry and State Affairs, shares policy perspectives.

Cannabis Drug Beats Opioids in Phase 3 Low Back Pain Trial

VER-01, a cannabis extract, outperformed both placebo and opioids in two late-stage clinical trials.

NCCI Publishes 2025 Regulatory and Legislative Trends Report

NCCI tracked 950 bills impacting workers’ comp, highlighting key trends across the country, such as PTSD and cancer presumptions, worker classification, and psychedelics.